Arnon Nagler
机构: Professor of Medicine,Tel Aviv University
每年引用次数
引用次数
引用: 87,530
H-指数: 135
I10-指数 : 1,038
出版物: 2,897
Cord blood - from a disposable byproduct of human birth into a precious source for life saving therapies
Nagler Arnon , Goldstein Gal , Toren Amos
Cellular Therapy and Transplantation 1 ( 1)
2008
Extrafollicular PD1 and Intrafollicular CD3 Expression Are Associated With Survival in Follicular Lymphoma
Kedmi Meirav , Schiby Ginette , Tadmor Tamar , Barshack Iris
Clinical Lymphoma Myeloma and Leukemia 17 ( 10) 645 -649
2
2017
Prolongation of Post Relapse and Overall Survival in Patients with Multiple Myeloma by Salvage Strategy with the Combination of Thalidomide and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation Based on the Nature of Disease Progression after Autologous Bone Marrow Transplantation.
Izhar Hardan , Avichai Shimoni , Abraham Kneller , Abraham Avigdor
Blood 106 ( 11) 3494 -3494
2005
The use of Soybean Agglutinin (SBA) for Bone Marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation
Nagler Arnon , Morecki Shoshana , Slavin Shimon
Molecular Biotechnology 11 ( 2) 181 -194
1999
Rhinocerebral aspergillosis
Nelson C Goldman , Saah Daniel , Elidan Josef , Braverman Itzhak
Otolaryngology—Head and Neck Surgery 119 ( 5) 554 -555
2
1998
Lethal infectious complications after hematopoietic stem cell transplantation: progress and challenges in Infectious Diseases Working Party study
Styczynski Jan , Tridello Gloria , Koster Linda , Iacobelli Simona
BONE MARROW TRANSPLANTATION 76 -76
2018
Infectious Diseases Working Party Retrospective Study on HHV-6 encephalitis: clinical characteristics and outcome after allogeneic HSCT
Katherine Nora Ward , Per Ljungman , Jennifer Hoek , Jürgen Finke
BONE MARROW TRANSPLANTATION 1 435 -435
2018
ABO mismatch and haploidentical hematopoietic stem cell transplantation in AML-a report from the ALWP of the EBMT
Bipin N Savani , Myriam Labopin , Jonathan Canaani , Fabio Ciceri
BONE MARROW TRANSPLANTATION 1 -2
2016
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia.
Gambacorti Passerini Carlo , Antolini Laura , Piazza Rocco , Guilhot François
BLOOD 118 1608 -1608
2011
Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
Joseph Kapelushnik , Gabor Varadi , Arron Nagler
Journal of Pediatric Hematology Oncology 20 ( 3) 257 -259
12
1998
Neuroprotection by human umbilical cord blood- derived progenitors in ischemic brain injuries
Shimon Lecht , Philip Lazarovici , Hadar Arien-Zakay , Hadar Arien-Zakay
Archives Italiennes De Biologie 149 ( 2) 233 -245
19
2011
MAJOR MOLECULAR RESPONSE RATE AT ONE YEAR IS HIGHER IF PEGYLATED INTERFERON ALPHA-2B IS ADDED TO IMATINIB IN NON-HR CHRONIC MYELOID LEUKEMIA PATIENTS IN IMATINIB INDUCED COMPLETE HEMATOLOGICAL REMISSION in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 457-457
H Hjorth-Hansen , S Mustjoki , L Koskenveesa , T Bjoreman
Pensiero Scientifico / Ferrata Storti Foundation 95 457 -457
1
2010
Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group.
E Plouvier , V. Rocha , R Pasquini , A Nagler
Bone Marrow Transplantation 21
26
1998
Imatinib long term effects study: three years of follow-up and assessment
E Pogliani , L Tornaghi , F Pane , M Durosinmi
Haematologica 94
2009
Comparison between anti-thymocyte globulin and alemtuzumab as part of the melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies
A Zander , T Zabelina , A Parker , M Kiehl
In: BONE MARROW TRANSPLANTATION. (pp. S11 - S11). NATURE PUBLISHING GROUP (2004)
2004
Soluble tumor necrosis factor (sTNF) receptors: A possible prognostic marker for bone marrow transplantation-related complications
T Hahn , Z Weisman , L Weiss , A Nagler
Cytokines and Molecular Therapy 2 ( 4) 243 -250
21
1996
A retrospective IDWP-ALWP study on Candida infections in allogeneic haematopoietic stem cell transplant patients
G Tridello , Johan Maertens , M Michallet , C Cordonnier
Bone Marrow Transplantation 50
2015
Comparable survival for poor-risk cytogenetics AML in first complete remission after haploidentical donor or unrelated donor transplantation: a study from the ALWP of EBMT
Johan Maertens , M Labopin , G Socie , M Bernardi
Bone Marrow Transplantation 51
2016
Factors determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT
Johan Maertens , M Labopin , P Chevallier , G Socie
Bone Marrow Transplantation 50
2015
ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
Johan Maertens , M Labopin , G Schlimok , N Ifrah
Bone Marrow Transplantation 49
2014